9.5272
price down icon0.73%   -0.1128
 
loading
前日終値:
$9.64
開ける:
$9.7
24時間の取引高:
11,716
Relative Volume:
0.08
時価総額:
$524.49M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.70%
1か月 パフォーマンス:
-23.93%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$9.5296
$9.805
1週間の範囲:
Value
$8.225
$10.64
52週間の値動き範囲:
Value
$8.225
$13.50

Alumis Inc Stock (ALMS) Company Profile

Name
名前
Alumis Inc
Name
セクター
Healthcare (1195)
Name
電話
650-231-6625
Name
住所
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Name
職員
147
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
ALMS's Discussions on Twitter

ALMS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ALMS 9.5296 524.49M 0 0 0 0.00
VRTX 446.50 115.74B 10.63B -479.80M -1.35B 13.33
REGN 740.51 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.20 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.97 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.50 24.49B 3.30B -501.07M 1.03B 11.54

Alumis Inc (ALMS) 最新ニュース

pulisher
Nov 20, 2024

Alumis Inc. Reports Q3 2024 Financial Results and Advances Clinical Programs - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Protagonist, J&J’s oral IL-23 psoriasis data strong (but short) - BioWorld Online

Nov 19, 2024
pulisher
Nov 18, 2024

What is HC Wainwright's Forecast for Alumis FY2024 Earnings? - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Leerink Partnrs Has Weak Estimate for Alumis FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 14, 2024

Alumis Presents Data Highlighting ESK-001's Potential as a High-efficacy Oral Treatment for Systemic Lupus Erythematosus (SLE) at ACR Convergence 2024 - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Alumis' ESK-001 Shows Promise in Lupus Treatment, New Clinical Data Revealed at ACR 2024 | ALMS Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight - The Malaysian Reserve

Nov 14, 2024
pulisher
Nov 14, 2024

Towerview LLC Buys 70,000 Shares of Alumis Inc. (NASDAQ:ALMS) - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Alumis (NASDAQ:ALMS) Price Target Lowered to $26.00 at HC Wainwright - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Alumis (NASDAQ:ALMS) Given Overweight Rating at Cantor Fitzgerald - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Alumis Reports Third Quarter 2024 Financial Results and Highlights Recent Achievements - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Alumis Reports 93% Success in Psoriasis Trial, Q3 Loss Widens to $93.1M | ALMS Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 11, 2024

Analysts Set Alumis Inc. (NASDAQ:ALMS) Price Target at $27.50 - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

U.S. Energy (NASDAQ:USEG) Earns Sell Rating from Analysts at StockNews.com - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Chase (NYSE:CCF) Coverage Initiated by Analysts at StockNews.com - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Eventbrite, Inc. (NYSE:EB) Receives Average Rating of “Hold” from Brokerages - Defense World

Nov 11, 2024
pulisher
Nov 07, 2024

Alumis readies $300 million IPO ahead of Phase 3 trial for plaque psoriasis drug - MSN

Nov 07, 2024
pulisher
Nov 07, 2024

Uveitis Clinical Trials 2024: FDA Approvals, Medication, - openPR

Nov 07, 2024
pulisher
Nov 07, 2024

How to Take Advantage of moves in (ALMS) - Stock Traders Daily

Nov 07, 2024
pulisher
Nov 04, 2024

New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD - Quantisnow

Nov 04, 2024
pulisher
Nov 04, 2024

Alumis to Participate in Guggenheim's Inaugural Healthcare Innovation Conference - StockTitan

Nov 04, 2024
pulisher
Nov 03, 2024

Net Present Value Model: Alumis Inc’s ESK-001 - GlobalData

Nov 03, 2024
pulisher
Nov 01, 2024

Alumis (NASDAQ:ALMS) Rating Increased to Strong-Buy at Baird R W - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Oct 31, 2024
pulisher
Oct 31, 2024

Robert W. Baird Begins Coverage on Alumis (NASDAQ:ALMS) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Baird starts Alumis coverage with Outperform, $25 target - Investing.com India

Oct 31, 2024
pulisher
Oct 30, 2024

Baird starts Alumis coverage with Outperform, $25 target By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 27, 2024

When (ALMS) Moves Investors should Listen - Stock Traders Daily

Oct 27, 2024
pulisher
Oct 26, 2024

Blue Trust Inc. Purchases 307 Shares of Watsco, Inc. (NYSE:WSO) - Defense World

Oct 26, 2024
pulisher
Oct 25, 2024

This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - MSN

Oct 25, 2024
pulisher
Oct 23, 2024

Alumis (NASDAQ:ALMS) Stock Price Down 4.5%Time to Sell? - MarketBeat

Oct 23, 2024
pulisher
Oct 21, 2024

Alumis (NASDAQ:ALMS) Trading 3.1% HigherWhat's Next? - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

HC Wainwright Predicts Alumis' Q3 Earnings (NASDAQ:ALMS) - MarketBeat

Oct 21, 2024
pulisher
Oct 20, 2024

Analysts Set Curbline Properties (NYSE:CURB) PT at $24.19 - Defense World

Oct 20, 2024
pulisher
Oct 20, 2024

Ambev (NYSE:ABEV) Now Covered by StockNews.com - Defense World

Oct 20, 2024
pulisher
Oct 17, 2024

Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside - AOL

Oct 17, 2024
pulisher
Oct 17, 2024

Alumis (NASDAQ:ALMS) Shares Gap UpHere's Why - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

H.C. Wainwright sets Buy rating on Alumis stock, cites TYK2 inhibitor - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

H.C. Wainwright sets Buy rating on Alumis stock By Investing.com - Investing.com UK

Oct 17, 2024
pulisher
Oct 17, 2024

Alumis Inc. (NASDAQ:ALMS) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

(ALMS) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Shifts in the Psoriasis Market Suggest Strong Potential for Emerging Oral Therapies - GlobeNewswire Inc.

Oct 16, 2024
pulisher
Oct 16, 2024

Alumis (NASDAQ:ALMS) Stock Price Down 2.6%What's Next? - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Alumis (NASDAQ:ALMS) Shares Up 6.9%What's Next? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Millennium Management LLC Takes Position in Alumis Inc. (NASDAQ:ALMS) - MarketBeat

Oct 15, 2024
pulisher
Oct 13, 2024

Squarepoint Ops LLC Has $240,000 Stock Holdings in Forge Global Holdings, Inc. (NYSE:FRGE) - Defense World

Oct 13, 2024
pulisher
Oct 10, 2024

Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock' - Benzinga

Oct 10, 2024
pulisher
Oct 08, 2024

Cramer's Lightning Round: 'I like Target right here' - CNBC

Oct 08, 2024
pulisher
Oct 08, 2024

Uveitis Market Growth to Accelerate in Forecast Period - openPR

Oct 08, 2024
pulisher
Oct 08, 2024

Alumis (NASDAQ:ALMS) Trading Up 3.8%Time to Buy? - MarketBeat

Oct 08, 2024
pulisher
Oct 06, 2024

(ALMS) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 06, 2024

Alumis Inc (ALMS) 財務データ

Alumis Inc (ALMS) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Alumis Inc (ALMS) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Foresite Capital Management V,
10% Owner
Jul 01 '24
Buy
16.00
2,500,000
40,000,000
5,584,889
Tananbaum James B.
Director
Jul 01 '24
Buy
16.00
2,500,000
40,000,000
5,584,889
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):